A Post Market Cohort to Assess the Performance of the Spinal Modulation Neurostimulator System for the Management of Chronic Neuropathic Pain of the Foot and/or Lower Leg

Chronic Neuropathic Pain Clinical Trial

Official title:
A Post Market Cohort to Assess the Performance of the Spinal Modulation Neurostimulator System for the Management of Chronic Neuropathic Pain of the Foot and/or Lower Leg

Status Terminated

Clinical Trial Summary

14-SMI-2013 is a post market, observational, questionnaire based study to assess the effectiveness of the commercially available Axium neurostimulator in the management of neuropathic pain of the foot and/or lower limb

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02335489
Study type	Observational
Source	Abbott Medical Devices
Contact
Status	Terminated
Phase
Start date	March 2013
Completion date	November 2015

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT03259451` - Effectiveness of Repetitive Transcranial Magnetic Stimulation in the Treatment of Chronic Neuropathic Pain
Enrolling by invitation	`NCT01437332` - Molecular Mediators of Nerve Injury Signaling	N/A
Completed	`NCT00214955` - Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for the Management of Breakthrough Pain	Phase 3
Terminated	`NCT00189059` - Effects of Amitriptyline for the Treatment of Pain on Driving Performance and Cognition.	Phase 4
Recruiting	`NCT04936646` - Study of rTMS Analgesic Effect in Chronic Neuropathic Pain,	N/A
Terminated	`NCT01205516` - Methadone in Neuropathic Pain	Phase 4
Terminated	`NCT04287075` - Surgical Treatment of Chronic Neuropathic Pain
Recruiting	`NCT05537935` - Low Dose Naltrexone for Pain in Patients With HIV	Phase 4
Recruiting	`NCT05593237` - Transcranial Magnetic Stimulation for Chronic Neuropathic Pain	N/A
Terminated	`NCT00189072` - Effects of Gabapentin in the Treatment of Neuropathic Pain on Driving Performance and Cognition	Phase 4